Dr Ryan Boerner, MD | |
3705 Medical Pkwy, Ste 320, Austin, TX 78705-1023 | |
(512) 454-0392 | |
(512) 454-1233 |
Full Name | Dr Ryan Boerner |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 10 Years |
Location | 3705 Medical Pkwy, Austin, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275947558 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | R7955 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension Seton Medical Center Austin | Austin, TX | Hospital |
Seton Northwest Hospital | Austin, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Butler And Burns Ear Nose And Throat Associates | 5496668238 | 39 |
News Archive
Reducing the activity of a gene called FKBP12 in the brains of mice affected neuron-to-neuron communication (synapse) and increased both fearful memory and obsessive behavior, indicating the gene could provide a target for drugs to treat diseases such as autism spectrum disorder, obsessive-compulsive disease and others, said researchers from Baylor College of Medicine in Houston in a report in the current issue of the journal Neuron.
Imagine a sensor implanted in your body that signals when you're getting sick - almost like the "check engine" light in a car. That scenario sounds like pure fantasy, but it may be closer to reality than many people think, according to an article in the current edition of Chemical & Engineering News, ACS' weekly newsmagazine.
Enzon Pharmaceuticals, Inc. today announced that data from preclinical studies of three investigational messenger RNA (mRNA) antagonists based on the locked nucleic acid (LNA) technology platform have been accepted for poster presentation at the EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics, which is being held November 16-19 in Berlin, Germany.
In a Child Development study of daily diary descriptions of discrimination by minority adolescents, experiencing discrimination during the day was associated with compromised sleep quality that night, as well as feelings of greater daytime dysfunction and sleepiness the following day.
A new study published in the British Journal of Nutrition appears to back up the adage that a little of what you fancy does you good.
› Verified 4 days ago
Entity Name | Butler & Burns Ear Nose & Throat Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174505473 PECOS PAC ID: 5496668238 Enrollment ID: O20031118000766 |
News Archive
Reducing the activity of a gene called FKBP12 in the brains of mice affected neuron-to-neuron communication (synapse) and increased both fearful memory and obsessive behavior, indicating the gene could provide a target for drugs to treat diseases such as autism spectrum disorder, obsessive-compulsive disease and others, said researchers from Baylor College of Medicine in Houston in a report in the current issue of the journal Neuron.
Imagine a sensor implanted in your body that signals when you're getting sick - almost like the "check engine" light in a car. That scenario sounds like pure fantasy, but it may be closer to reality than many people think, according to an article in the current edition of Chemical & Engineering News, ACS' weekly newsmagazine.
Enzon Pharmaceuticals, Inc. today announced that data from preclinical studies of three investigational messenger RNA (mRNA) antagonists based on the locked nucleic acid (LNA) technology platform have been accepted for poster presentation at the EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics, which is being held November 16-19 in Berlin, Germany.
In a Child Development study of daily diary descriptions of discrimination by minority adolescents, experiencing discrimination during the day was associated with compromised sleep quality that night, as well as feelings of greater daytime dysfunction and sleepiness the following day.
A new study published in the British Journal of Nutrition appears to back up the adage that a little of what you fancy does you good.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ryan Boerner, MD 3705 Medical Pkwy, Ste 320, Austin, TX 78705-1023 Ph: (843) 792-3072 | Dr Ryan Boerner, MD 3705 Medical Pkwy, Ste 320, Austin, TX 78705-1023 Ph: (512) 454-0392 |
News Archive
Reducing the activity of a gene called FKBP12 in the brains of mice affected neuron-to-neuron communication (synapse) and increased both fearful memory and obsessive behavior, indicating the gene could provide a target for drugs to treat diseases such as autism spectrum disorder, obsessive-compulsive disease and others, said researchers from Baylor College of Medicine in Houston in a report in the current issue of the journal Neuron.
Imagine a sensor implanted in your body that signals when you're getting sick - almost like the "check engine" light in a car. That scenario sounds like pure fantasy, but it may be closer to reality than many people think, according to an article in the current edition of Chemical & Engineering News, ACS' weekly newsmagazine.
Enzon Pharmaceuticals, Inc. today announced that data from preclinical studies of three investigational messenger RNA (mRNA) antagonists based on the locked nucleic acid (LNA) technology platform have been accepted for poster presentation at the EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics, which is being held November 16-19 in Berlin, Germany.
In a Child Development study of daily diary descriptions of discrimination by minority adolescents, experiencing discrimination during the day was associated with compromised sleep quality that night, as well as feelings of greater daytime dysfunction and sleepiness the following day.
A new study published in the British Journal of Nutrition appears to back up the adage that a little of what you fancy does you good.
› Verified 4 days ago
Robert A. Williamson Jr., M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6811 Austin Center Blvd, Suite 300, Austin, TX 78731 Phone: 512-346-8888 Fax: 512-406-7321 | |
Dr. Jeffrey S Zapalac, M.D., F.A.C.S. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy, Suite 310, Austin, TX 78705 Phone: 512-458-6391 Fax: 512-390-4091 | |
Dr. Joel William Jones, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 9835 N Lake Creek Pkwy, Austin, TX 78717 Phone: 832-822-0629 | |
Dr. Tibor Ruff, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 40 N Interstate 35 Apt 9d1, Austin, TX 78701 Phone: 512-947-4612 | |
James R Eskew, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4315 James Casey St, Suite 300, Austin, TX 78745 Phone: 512-444-7944 Fax: 512-444-7946 | |
Kent P Jones, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6811 Austin Center Blvd # 300, Austin, TX 78731 Phone: 512-346-8888 Fax: 512-344-0340 | |
David Crockett Teller, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 7901 Metropolis Dr, Austin, TX 78744 Phone: 512-823-4880 Fax: 512-823-4155 |